Susan C. Adeniyi-Jones, MD
NeonatologistFellowship
- Neonatology - Children's Hospital of Buffalo, 1987
- Endocrinology - National Institute of Child Health, 1985
Internship
- Selly Oak Teaching Hospital, 1978
- The Walsgrave Hospital, 1977
Residency
- Pediatrics - The Hospital for Sick Children, 1981
- Pediatrics - The Children's Hospital, 1980
- Pediatrics - Queen Elizabeth II & St. Alban
Education
- M.D. - Birmingham University Medical School, 1977
Board Certifications
- American Board of Pediatrics/General Pediatrics
- American Board of Pediatrics/Neonatal-Perinatal
-
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study; Journal of Perinatology; (2025).
-
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS); Journal of Perinatology; (2024).
-
Algorithms for treatment of Neonatal Opioid Withdrawal Syndrome (NOWS) based on Modified and Abbreviated Finnegan Symptom Score; Unknown Source; (2023).
-
Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial; Journal of Perinatology; (2023).
-
Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome.; Pediatric research; (2022).
-
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome; Clinical and Translational Science; (2021).
-
The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome; Clinical Pharmacology & Therapeutics; (2018).
-
Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.; The New England journal of medicine; (2017).